BMY — Bristol-Myers Squibb Company · P/E 17, rev $24.46B

Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..

Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.

Use this BMY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BMY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BMY SEC filings page. Lician reads the product cache first so this HTML stays unique to Bristol-Myers Squibb Company even when a live quote feed is slow.